July 10, 2023
The first-ever drug approved to slow the rate of Alzheimer's disease has been approved by the FDA for sale in the US. Leqembi, which is made by the companies Eisei and Biogen, has been found to slow symptom progression by 27%. “Leqembi is the first fully FDA approved…